Cargando…

A Malawian pharmaceutical response to the COVID-19 Pandemic

The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kachingwe, Baxter, Kumpalume, Peter, Khuluza, Felix, Nyirenda, Kumbukani, Matambo, Ernest, Mponda, John, Dzabala, Nettie, Chiumia, Francis, Chikowe, Ibrahim, Chimimba, Frider, Nyoloka, Nelson, Alfazema, Louisa, Nyirongo, Happy, Smith, Dallas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Medical Association Of Malawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230587/
https://www.ncbi.nlm.nih.gov/pubmed/37265827
http://dx.doi.org/10.4314/mmj.v34i1.11
_version_ 1785051565359366144
author Kachingwe, Baxter
Kumpalume, Peter
Khuluza, Felix
Nyirenda, Kumbukani
Matambo, Ernest
Mponda, John
Dzabala, Nettie
Chiumia, Francis
Chikowe, Ibrahim
Chimimba, Frider
Nyoloka, Nelson
Alfazema, Louisa
Nyirongo, Happy
Smith, Dallas
author_facet Kachingwe, Baxter
Kumpalume, Peter
Khuluza, Felix
Nyirenda, Kumbukani
Matambo, Ernest
Mponda, John
Dzabala, Nettie
Chiumia, Francis
Chikowe, Ibrahim
Chimimba, Frider
Nyoloka, Nelson
Alfazema, Louisa
Nyirongo, Happy
Smith, Dallas
author_sort Kachingwe, Baxter
collection PubMed
description The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi, the Kamuzu University of Health Science's Department of Pharmacy initiated the production of a modified formulation of the World Health Organization's (WHO) recommended hand sanitizer. This manufacturing venture involved mobilizing the pharmacy faculty, identifying gaps in supplies and equipment, and utilizing evidenced-based information to create a high-quality sanitation product, which passed the requirements as tested by the Malawi Bureau of Standards. The department of pharmacy is expanding their distribution of the product to meet the needs of frontline healthcare workers and vulnerable populations. With historical issues of accessing care in Malawi and with COVID-19's spread among healthcare workers, this hand sanitizer venture is vital in the public healthcare's system response. The department of pharmacy will continue to lead the pharmacy profession in Malawi to provide targeted interventions in this unprecedented time.
format Online
Article
Text
id pubmed-10230587
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Medical Association Of Malawi
record_format MEDLINE/PubMed
spelling pubmed-102305872023-06-01 A Malawian pharmaceutical response to the COVID-19 Pandemic Kachingwe, Baxter Kumpalume, Peter Khuluza, Felix Nyirenda, Kumbukani Matambo, Ernest Mponda, John Dzabala, Nettie Chiumia, Francis Chikowe, Ibrahim Chimimba, Frider Nyoloka, Nelson Alfazema, Louisa Nyirongo, Happy Smith, Dallas Malawi Med J Case Report The COVID-19 pandemic has elicited swift and innovative responses due to the severity of the outbreak. Higher education institutions worldwide with pharmacy programs have identified vital gaps in COVID-19 care and has undertaken proactive steps to aid in the fight against the coronavirus. In Malawi, the Kamuzu University of Health Science's Department of Pharmacy initiated the production of a modified formulation of the World Health Organization's (WHO) recommended hand sanitizer. This manufacturing venture involved mobilizing the pharmacy faculty, identifying gaps in supplies and equipment, and utilizing evidenced-based information to create a high-quality sanitation product, which passed the requirements as tested by the Malawi Bureau of Standards. The department of pharmacy is expanding their distribution of the product to meet the needs of frontline healthcare workers and vulnerable populations. With historical issues of accessing care in Malawi and with COVID-19's spread among healthcare workers, this hand sanitizer venture is vital in the public healthcare's system response. The department of pharmacy will continue to lead the pharmacy profession in Malawi to provide targeted interventions in this unprecedented time. The Medical Association Of Malawi 2022-03 /pmc/articles/PMC10230587/ /pubmed/37265827 http://dx.doi.org/10.4314/mmj.v34i1.11 Text en © 2022 The College of Medicine and the Medical Association of Malawi. https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Case Report
Kachingwe, Baxter
Kumpalume, Peter
Khuluza, Felix
Nyirenda, Kumbukani
Matambo, Ernest
Mponda, John
Dzabala, Nettie
Chiumia, Francis
Chikowe, Ibrahim
Chimimba, Frider
Nyoloka, Nelson
Alfazema, Louisa
Nyirongo, Happy
Smith, Dallas
A Malawian pharmaceutical response to the COVID-19 Pandemic
title A Malawian pharmaceutical response to the COVID-19 Pandemic
title_full A Malawian pharmaceutical response to the COVID-19 Pandemic
title_fullStr A Malawian pharmaceutical response to the COVID-19 Pandemic
title_full_unstemmed A Malawian pharmaceutical response to the COVID-19 Pandemic
title_short A Malawian pharmaceutical response to the COVID-19 Pandemic
title_sort malawian pharmaceutical response to the covid-19 pandemic
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230587/
https://www.ncbi.nlm.nih.gov/pubmed/37265827
http://dx.doi.org/10.4314/mmj.v34i1.11
work_keys_str_mv AT kachingwebaxter amalawianpharmaceuticalresponsetothecovid19pandemic
AT kumpalumepeter amalawianpharmaceuticalresponsetothecovid19pandemic
AT khuluzafelix amalawianpharmaceuticalresponsetothecovid19pandemic
AT nyirendakumbukani amalawianpharmaceuticalresponsetothecovid19pandemic
AT matamboernest amalawianpharmaceuticalresponsetothecovid19pandemic
AT mpondajohn amalawianpharmaceuticalresponsetothecovid19pandemic
AT dzabalanettie amalawianpharmaceuticalresponsetothecovid19pandemic
AT chiumiafrancis amalawianpharmaceuticalresponsetothecovid19pandemic
AT chikoweibrahim amalawianpharmaceuticalresponsetothecovid19pandemic
AT chimimbafrider amalawianpharmaceuticalresponsetothecovid19pandemic
AT nyolokanelson amalawianpharmaceuticalresponsetothecovid19pandemic
AT alfazemalouisa amalawianpharmaceuticalresponsetothecovid19pandemic
AT nyirongohappy amalawianpharmaceuticalresponsetothecovid19pandemic
AT smithdallas amalawianpharmaceuticalresponsetothecovid19pandemic
AT kachingwebaxter malawianpharmaceuticalresponsetothecovid19pandemic
AT kumpalumepeter malawianpharmaceuticalresponsetothecovid19pandemic
AT khuluzafelix malawianpharmaceuticalresponsetothecovid19pandemic
AT nyirendakumbukani malawianpharmaceuticalresponsetothecovid19pandemic
AT matamboernest malawianpharmaceuticalresponsetothecovid19pandemic
AT mpondajohn malawianpharmaceuticalresponsetothecovid19pandemic
AT dzabalanettie malawianpharmaceuticalresponsetothecovid19pandemic
AT chiumiafrancis malawianpharmaceuticalresponsetothecovid19pandemic
AT chikoweibrahim malawianpharmaceuticalresponsetothecovid19pandemic
AT chimimbafrider malawianpharmaceuticalresponsetothecovid19pandemic
AT nyolokanelson malawianpharmaceuticalresponsetothecovid19pandemic
AT alfazemalouisa malawianpharmaceuticalresponsetothecovid19pandemic
AT nyirongohappy malawianpharmaceuticalresponsetothecovid19pandemic
AT smithdallas malawianpharmaceuticalresponsetothecovid19pandemic